Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | JNK-IN-11 | 0.3 | uM | 3 | IL-12 (p70) | 42.0 | 39 | ||||
| RA2159 | 3 | IL-12 (p70) | 46.0 | 60 | |||||||
| RA2159 | PD184352 | 0.1 | uM | 3 | IL-12 (p70) | 68.0 | 53 | ||||
| RA2159 | Lestaurtinib | 0.3 | uM | 3 | IL-12 (p70) | 55.5 | 54 | ||||
| RA2159 | Ruxolitinib | 0.3 | uM | 3 | IL-12 (p70) | 49.0 | 58 | ||||
| RA2159 | Tofacitinib | 0.3 | uM | 3 | IL-12 (p70) | 43.0 | 67 | ||||
| RA2159 | IKK16 | 2.0 | uM | 3 | IL-12 (p70) | 44.0 | 71 | ||||
| RA2159 | JNK-IN-8 | 3.0 | uM | 3 | IL-12 (p70) | 36.0 | 69 | ||||
| N2586 | 3 | IL-12 (p70) | 62.5 | 62 | |||||||
| N2586 | PD184352 | 0.1 | uM | 3 | IL-12 (p70) | 57.0 | 58 | ||||
| N2586 | Lestaurtinib | 0.3 | uM | 3 | IL-12 (p70) | 52.0 | 72 | ||||
| N2586 | Ruxolitinib | 0.3 | uM | 3 | IL-12 (p70) | 65.0 | 67 | ||||
| N2586 | Tofacitinib | 0.3 | uM | 3 | IL-12 (p70) | 84.5 | 68 | ||||
| N2586 | IKK16 | 2.0 | uM | 3 | IL-12 (p70) | 51.0 | 67 | ||||
| N2586 | JNK-IN-8 | 3.0 | uM | 3 | IL-12 (p70) | 75.0 | 53 | ||||
| RA2159 | IL-17A | 100 | ng/mL | 3 | IL-12 (p70) | 53.0 | 54 | ||||
| RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | IL-12 (p70) | 93.0 | 69 | |
| RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-12 (p70) | 60.0 | 72 | |
| RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-12 (p70) | 56.0 | 75 | |
| RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-12 (p70) | 52.5 | 60 | |
| RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | IL-12 (p70) | 55.0 | 67 | |
| N2586 | IL-17A | 100 | ng/mL | 3 | IL-12 (p70) | 65.0 | 64 | ||||
| N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | IL-12 (p70) | 70.0 | 84 | |
| N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-12 (p70) | 31.0 | 58 | |
| N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-12 (p70) | 59.0 | 71 |